New Drug: Margetuximab for her2-positive metastatic breast cancer
|New Drug: Margetuximab for her2-positive metastatic breast cancer|
Presented at 2019 SABCS
Rugo HS, et al. Phase 3 SOPHIA study of margetuximab + chemotherapy vs trastuzumab + chemotherapy in patients with HER2+ metastatic breast cancer after prior anti-HER2 therapies: second interim overall survival analysishttps://www.abstractsonline.com/pp8/#!/7946/presentation/2038
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.